The Current Ratio as of December 2025 (TTM) for Neumora Therapeutics, Inc. Common Stock (NMRA) is 6.85

According to Neumora Therapeutics, Inc. Common Stock’s latest financial reports and current stock price. The company's current Current Ratio is 6.85. This represents a change of -25.67% compared to the average of 9.22 of the last 4 quarters.

Neumora Therapeutics, Inc. Common Stock (NMRA) Historical Current Ratio (quarterly & annually)

How has NMRA Current Ratio performed in the past?

The mean historical Current Ratio of Neumora Therapeutics, Inc. Common Stock over the last ten years is 14.08. The current 6.85 Current Ratio has changed 4.77% with respect to the historical average. Over the past ten years (40 quarters), NMRA's Current Ratio was at its highest in in the September 2021 quarter at 21.15. The Current Ratio was at its lowest in in the March 2021 quarter at 0.

Neumora Therapeutics, Inc. Common Stock (NMRA) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Neumora Therapeutics, Inc. Common Stock Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Neumora Therapeutics, Inc. Common Stock (NMRA) Average Current Ratio

How has NMRA Current Ratio performed in the past?

The current Current Ratio of Neumora Therapeutics, Inc. Common Stock (NMRA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Neumora Therapeutics, Inc. Common Stock (NMRA) Current Ratio vs. Peers

How is NMRA’s Current Ratio compared to its peers?

Neumora Therapeutics, Inc. Common Stock’s Current Ratio is less than RAPT Therapeutics, Inc. (12.04), less than Bicycle Therapeutics plc (10.66), greater than Omeros Corporation (0.89), greater than ADC Therapeutics S.A. (4.93), greater than Lexicon Pharmaceuticals, Inc. (4.16), greater than Alumis Inc. Common Stock (6.01), less than Fulcrum Therapeutics, Inc. (17.70), less than 4D Molecular Therapeutics, Inc. (8.42), greater than Prothena Corporation plc (6.61), less than Autolus Therapeutics plc (8.43),

Build a custom stock screener for Neumora Therapeutics, Inc. Common Stock (NMRA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Neumora Therapeutics, Inc. Common Stock using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Neumora Therapeutics, Inc. Common Stock (NMRA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Neumora Therapeutics, Inc. Common Stock or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.